No abstract available
Keywords:
adverse events; heart failure; immune checkpoint inhibitor; melanoma; myocarditis.
MeSH terms
-
Acute Disease
-
Aged
-
Antibodies, Monoclonal / adverse effects*
-
Antineoplastic Agents, Immunological / adverse effects*
-
Biopsy
-
Choroid Neoplasms / drug therapy*
-
Choroid Neoplasms / immunology
-
Choroid Neoplasms / pathology
-
Female
-
Glucocorticoids / therapeutic use
-
Humans
-
Immunohistochemistry
-
Lymphocytosis / chemically induced*
-
Lymphocytosis / diagnosis
-
Lymphocytosis / drug therapy
-
Lymphocytosis / physiopathology
-
Melanoma / drug therapy*
-
Melanoma / immunology
-
Melanoma / secondary
-
Myocarditis / chemically induced*
-
Myocarditis / diagnosis
-
Myocarditis / drug therapy
-
Myocarditis / physiopathology
-
Nivolumab
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
-
Programmed Cell Death 1 Receptor / immunology
-
Tomography, X-Ray Computed
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antineoplastic Agents, Immunological
-
Glucocorticoids
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor
-
Nivolumab